专题：Gastrointestinal Tumor Research and Treatment

This cluster of papers focuses on the diagnosis and treatment of gastrointestinal stromal tumors (GISTs), including the efficacy and safety of targeted therapies like Imatinib Mesylate and Sunitinib, the role of PDGFRA and KIT mutations in GISTs, consensus approaches for management, surgical considerations, prognostic factors, use of EUS-guided fine needle aspiration, and the significance of succinate dehydrogenase (SDH) deficiency. It also explores the use of PET imaging for response evaluation.
最新文献
Safety-Ensured Robotic Control Framework for Cutting Task Automation in Endoscopic Submucosal Dissection

article Full Text OpenAlex

Imatinib Desensitization After a Type IV Hypersensitivity Reaction in a Gastrointestinal Stromal Tumor Patient—A Case Report

article Full Text OpenAlex

The Landmark Series: Minimally Invasive Pancreatic Resection for Ductal Adenocarcinoma, Updates, Trends, and Future Considerations

review Full Text OpenAlex

Negative Effect of Prior Lesion Manipulation on Colorectal Endoscopic Submucosal Dissection Outcomes: A Retrospective Cohort Study

article Full Text OpenAlex

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

article Full Text OpenAlex

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

article Full Text OpenAlex

Critical Aspects into Surgical Management, Classification, and Therapeutic Guidelines for Incidental GISTs During Bariatric Surgeries

article Full Text OpenAlex

Comparison of outcomes between surgery and non-surgery after conversion therapy for advanced gastric cancer with unresectable factors: a systematic review and meta-analysis

review Full Text OpenAlex

Cancer-associated fibroblast-derived fibulin-5 promotes epithelial–mesenchymal transition in diffuse-type gastric cancer via cAMP response element-binding protein pathway, showing poor prognosis

article Full Text OpenAlex

Safety and Feasibility of Novel Single-Port Robotic-Assisted Lobectomy/Segmentectomy for Lung Cancer

article Full Text OpenAlex

近5年高被引文献
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

article Full Text OpenAlex 2095 FWCI306.843

Current treatment and recent progress in gastric cancer

review Full Text OpenAlex 1338 FWCI55.09

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

article Full Text OpenAlex 1333 FWCI275.714

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 1147 FWCI235.122

Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)

article Full Text OpenAlex 752 FWCI147.003

Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial

article Full Text OpenAlex 532 FWCI109.531

Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial

article Full Text OpenAlex 490 FWCI72.249

Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2022

article Full Text OpenAlex 469 FWCI93.061

Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2021

article Full Text OpenAlex 431 FWCI73.864

Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

article Full Text OpenAlex 410 FWCI66.716